From Cannabis Clinics to Bitcoin Billions: KindlyMD (NAKA) Stock’s Wild 2025 Ride
Market Analysis & Forecast: For now, analysts and investors appear in “wait and see” mode. Near-term catalysts will be pivotal. These include the finalization (or not) of the Antalpha $250M convertible deal – which would inject capital but on what terms? – and the company’s next earnings report (to show if core healthcare revenue is growing or still minuscule). If Bitcoin’s price continues to climb in late 2025, it could boost KindlyMD’s asset value and perhaps its stock; conversely, a crypto downturn or interest rate spike could hurt both the value of its BTC and its ability to raise funds
